Antithrombotic therapy after bioprosthetic aortic valve replacement

Aramendi, Jose I.; Mestres, Carlos-A.
April 2008
European Journal of Cardio-Thoracic Surgery;Apr2008, Vol. 33 Issue 4, p529
Academic Journal
No abstract available.


Related Articles

  • Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Colli, Andrea; Verhoye, Jean-Philippe; Heijmen, Robin; Strauch, Justus Thomas; Hyde, Jonathan A.J.; Pagano, Domenico; Antunes, Manuel; Koertke, Heinrich; Ohri, Sunil Kumar; Bail, Dorothee Helene Lina; Leprince, Pascal; Van Straten, Bart H.M.; Gherli, Tiziano // European Journal of Cardio-Thoracic Surgery;Apr2008, Vol. 33 Issue 4, p531 

    Abstract: Aims: A variety of antithrombotic regimens have been described for the early postoperative period after bioprosthetic aortic valve replacement (AVR). This study reviews antithrombotic practice for patients undergoing bioprosthetic AVR with or without coronary artery bypass graft (CABG)...

  • Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue. Colli, Andrea; Verhoye, Jean-Philippe; Leguerrier, Alain; Gherli, Tiziano // European Journal of Cardio-Thoracic Surgery;Apr2007, Vol. 31 Issue 4, p573 

    Summary: Improvements in the performance and longevity of biological valve prostheses have steadily increased their rates of implantation in recent years. Aortic bioprostheses, which are commonly used in the elderly or when the risks of anticoagulating are high, have generally been associated...

  • Warfarin Treatment After Bioprosthetic Aortic Valve Replacement. Mérie, Charlotte; Køber, Lars; Torp-Pedersen, Christian // JAMA: Journal of the American Medical Association;3/27/2013, Vol. 309 Issue 12, p1225 

    A letter to the editor is presented in response to an article related to discontinuation of warfarin treatment after bioprosthetic aortic valve replacement.

  • Warfarin After Bioprosthetic Aortic Valve Implantation. Mehta, Shamir R.; Weitz, Jeffrey I. // JAMA: Journal of the American Medical Association;11/28/2012, Vol. 308 Issue 20, p2147 

    In this article, the author focuses on the usage of Warfarin, an anticoagulant, after bioprosthetic Aortic Valve implantation. He mentions that around 170000 patients in the U.S. undergo aortic valve replacement every year with majority of the patients opt for bioprosthetic rather than a...

  • Anticoagulation and AVR. Elliott, William T. // Primary Care Reports;Jan2013 Pharmacology Watch, p1 

    The article discusses a study from Denmark determining the optimal duration for use of anticoagulation for patients after the bioprosthetic aortic valve replacement (AVR) surgery. The study reveals that discontinuing warfarin within 6 months of bioprosthetic AVR surgery was related with...

  • ANTICOAGULANTS AFTER VALVE REPLACEMENT. Bussey, Walter; Kleinschmidt, Debra // Clinical Advisor;Jul2010, Vol. 13 Issue 7, p37 

    A question and answer are presented about anticoagulation therapy following bioprosthetic valve replacement.

  • Early bioprosthetic valve calcification with alfacalcidol supplementation. Takano, Tamaki; Terasaki, Takamitsu; Wada, Yuko; Ohashi, Noburou; Komatsu, Kazunori; Fukui, Daisuke; Amano, Jun // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue 1, p1 

    We report a case of early bioprosthetic valve calcification in a 76 year-old woman who had received supplementation with alfacalcidol, an analogue of vitamin D, for 3 years after her initial valve replacement. She underwent aortic valve replacement at the age of 71 and subsequently complained of...

  • Antithrombotic therapy after transcatheter aortic valve implantation. Iung, Bernard // Heart;Jul2015, Vol. 101 Issue 14, p1089 

    The author reflects on the administration of Antithrombotic therapy after transcatheter aortic valve implantation (TAVI) and its associated risk. Topics discussed include bleeding, acute coronary syndrome and strokes in patients that are prescribed aspirin after TAVI, difference in...

  • Delirium and Takotsubo cardiomyopathy following cardiac surgery. Wang, L. W.; Jansz, P. C.; Baron, D. W. // Anaesthesia & Intensive Care;May2013, Vol. 41 Issue 3, p437 

    The article reports a case of Takotsubo cardiomyopathy in an elderly woman after elective coronary artery bypass surgery and bioprosthetic aortic valve replacement for severe aortic valve stenosis. There was no preoperative cognitive impairment, with hypothyroidism as the only medical...

  • Antithrombotic Therapy After Transcatheter Aortic Valve Replacement. Hough, Augustus; Woods, Daniel // JAMA: Journal of the American Medical Association;3/26/2014, Vol. 311 Issue 12, p1249 

    A letter to the editor is presented in response to an article about antithrombotic therapy following transcatheter aortic valve replacement (TAVR) that was published in a 2014 issue of the "Journal of the American Medical Association" (JAMA).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics